AstraZeneca says its Oxford vaccine deal allows it to add up to 20per cent of manufacturing costs

AstraZeneca Plc said on Friday its coronavirus vaccine deal with Oxford University will allow it to add up to 20per cent of manufacturing costs to cover additional expenses required to be incurred by the British drugmaker.